Brookfield Corporation (BN.PF.C) Quote

I know a bit about kosher...lol.

S.O.S

Were is Mark Newbauer?

Still? lol

Just so I understand, a "third-party" promoter paid for the fake report?

Very suspicious being XCRT shareholders have been told for the last 2 years 3rd party promoters did not exist around XCRT and any such suggestion was called bashing?

Stunning revelation?

Me either. I have never understood the APES.

if you are talking about trust preferred - like WaMu had --- that is not what they are at all

Ty...feel free to pm me with dino picks...I'm riding free on ihub,only because I feel they're part of the sham... I would just send you a public ty.

volume creeping up each day , that is a good indicator

holo head fake lol

Solid
Investment
Op

Melvin Capital screwed up. Plotkin won't do that again, though there're many ways to screw up.

Ok I'll come right out and ask. You have 2 picks you can toss my way? I'll give them a shot.

U have the wrong link. Check this one . https://tptglobaltech.com/

Part of the Bauman-Lowenthal_Lumb scamming team

Ring the run baby!!! If we see a dollar then we see multi dollar volume!! Especially if audit comes in and then uplist news. What a senario lol. Let’s go!!! Holding my .05

tradeherpete,

ALZ-801/valiltramiprosate

https://alzheon.com/pipeline/alzheon-alz-801/

This was the other drug candidate mentioned in the video besides Anavex's blarcamesine.

Good luck and GOD bless,

FFS. I consider TA when trading. ( I rarely buy when the RSI is over 80 for instance ) but I am not ruled by it .
Fundamental news dictated the price action today .
If Denner were to make a large open market purchase of AMRN shares tomorrow ..that would drive PPS higher regardless of

I’d venture for Stephen Craig Lumb

I think the mails sent supposedly to Lowenthà are just fake

Just put in a small buy order ,trying to get some cheapies at the open.

I can't help but think about what it has got to be like to be 77 and still be out there swinging. Over the last couple of year Lowenthal's profile has gotten more public and more robust. Like this: "His expertise spans decades and multiple continents, making him a significant figure in these fields.

Mk, European expansion should allow for increased purchase of API. That would reduce cost. Same goes for China and ROW. The generic companies only have a market in the US. They have limited purchasing options. The next eight to ten months will be brutal. After that, we should be able to undercut gen